PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (1S)-1-NAPHTHYLETHYLAMINE | 436-100-1 | - | - | - | - | - | 1 | - | - | - | - | Details |
| (1S)-1-phenylpropan-1-amine | 455-040-5 | 3789-59-1 | - | - | - | - | 1 | - | - | - | - | Details |
| (1S)-3,7,7-trimethylbicyclo[4.1.0]hept-3-ene | 207-856-6 | 498-15-7 | - | - | 1 | - | - | - | - | - | - | Details |
| (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol | 805-440-4 | 22972-51-6 | - | - | - | - | 1 | - | - | - | - | Details |
| (1S,5R)-6,8-dioxabicyclo[3.2.1]octan-4-one | 807-130-4 | 53716-82-8 | - | - | 1 | - | - | - | - | - | - | Details |
| (1S,5S)-2,6,6-trimethylbicyclo[3.1.1]hept-2-ene | 232-077-3 | 7785-26-4 | - | - | 2 | - | - | - | - | - | - | Details |
| (1α,2α,3β,6β)-1,2,3,6-tetrahydro-3,6-methanophthalic anhydride | 220-384-5 | 2746-19-2 | - | - | - | - | 1 | - | - | - | - | Details |
| (1α,2β,5α)-2,6,6-trimethylbicyclo[3.1.1]heptane | 229-978-9 | 6876-13-7 | - | - | - | - | 1 | - | - | - | - | Details |
| (2,3-dimethylbut-2-yl)-trimethoxysilane | 439-360-2 | 142877-45-0 | - | - | - | - | 1 | - | - | - | - | Details |
| (2,4,6-trioxo-1,3,5-triazine-1,3,5(2H,4H,6H)-triyl)tri-2,1-ethanediyl triacrylate | 254-843-6 | 40220-08-4 | - | - | 1 | - | - | - | - | - | - | Details |